CoChat

How Biofilms Evade Host Defenses

Roilides, Emmanuel, Simitsopoulou, Maria, Katragkou, Aspasia, Walsh, Thomas J. · 2015 · Microbiology Spectrum
Cited by 157

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

The steps involved during the biofilm growth cycle include attachment to a substrate followed by more permanent adherence of the microorganisms, microcolony arrangement, and cell detachment required for the dissemination of single or clustered cells to other organ systems. Various methods have been developed for biofilm detection and quantitation. Biofilm-producing microorganisms can be detected in tissue culture plates, using silicone tubes and staining methods, and by visual assessment using scanning electron microscopy or confocal scanning laser microscopy. Quantitative measurement of biofilm growth is determined by using methods that include dry cell weight assays, colony-forming-unit counting, DNA quantification, or XTT 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide reduction assay. Upon infection, innate immune defense strategies are able to establish an immediate response through effector mechanisms mediated by immune cells, receptors, and several humoral factors. We present an overview of the life cycle of biofilms and their diversity, detection methods for biofilm development, and host immune responses to pathogens. We then focus on current concepts in bacterial and fungal biofilm immune evasion mechanisms. This appears to be of particular importance because the use of host immune responses may represent a novel therapeutic approach against biofilms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/microbiolspec.mb-0012-2014

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 78

  1. Costerton JW Geesey GG Cheng KJ. 1978. How bacteria stick. Sci Am 238: 86–95. [PubMed][CrossRef] · DOI · Paper page
  2. Costerton JW Lewandowski Z Caldwell DE Korber DR Lappin-Scott HM. 1995. Microbial biofilms. Annu Rev Microbiol 49: 711–745. [PubMed][CrossRef] · DOI · Paper page
  3. Costerton JW Stewart PS Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284: 1318–1322. [PubMed][CrossRef] · DOI · Paper page
  4. Mack D Becker P Chatterjee I Dobinsky S Knobloch JK Peters G Rohde H Herrmann M. 2004. Mechanisms of biofilm formation in Staphylococcus epidermidis and Staphylococcus aureus : functional molecules regulatory circuits and adaptive responses. Int J Med Microbiol 294: 203–212. [PubMed][CrossRef] · DOI · Paper page
  5. Wei Q Ma LZ. 2013. Biofilm matrix and its regulation in Pseudomonas aeruginosa . Int J Mol Sci 14: 20983–21005. [PubMed][CrossRef] · DOI · Paper page
  6. Palkova Z Vachova L. 2006. Life within a community: benefit to yeast long-term survival. FEMS Microbiol Rev 30: 806–824. [PubMed][CrossRef] · DOI · Paper page
  7. Donlan RM. 2001. Biofilms and device-associated infections. Emerg Infect Dis 7: 277–281. [PubMed][CrossRef] · DOI · Paper page
  8. Salta M Wharton JA Blache Y Stokes KR Briand JF. 2013. Marine biofilms on artificial surfaces: structure and dynamics. Environ Microbiol . [Epub ahead of print.] doi:10.1111/1462-2920.12186. [PubMed][CrossRef] · DOI · Paper page
  9. Abdallah M Benoliel C Drider D Dhulster P Chihib NE. 2014. Biofilm formation and persistence on abiotic surfaces in the context of food and medical environments. Arch Microbiol . [Epub ahead of print.] doi:10.1007/s00203-014-0983-1. [CrossRef] · DOI · Paper page
  10. Otto M. 2008. Staphylococcal biofilms. Curr Top Microbiol Immunol 322: 207–228. [PubMed][CrossRef] · DOI · Paper page
  11. Fey PD Olson ME. 2010. Current concepts in biofilm formation of Staphylococcus epidermidis . Future Microbiol 5: 917–933. [PubMed][CrossRef] · DOI · Paper page
  12. Moorthy S Watnick PI. 2004. Genetic evidence that the Vibrio cholerae monolayer is a distinct stage in biofilm development. Mol Microbiol 52: 573–587. [PubMed][CrossRef] · DOI
  13. Caiazza NC Merritt JH Brothers KM O’Toole GA. 2007. Inverse regulation of biofilm formation and swarming motility by Pseudomonas aeruginosa PA14. J Bacteriol 189: 3603–3612. [PubMed][CrossRef] · DOI · Paper page
  14. Walsh TJ Schlegel R Moody M Costerton JW Salcman M. 1986. Ventriculo-atrial shunt infection due to Cryptococcus neoformans : an ultrastructural and quantitative microbiological study. Neurosurgery 18: 373–375. [PubMed][CrossRef] · DOI
  15. Martinez LR Casadevall A. 2005. Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy. Infect Immun 73: 6350–6362. [PubMed][CrossRef] · DOI · Paper page
  16. Zhao X Oh SH Yeater KM Hoyer LL. 2005. Analysis of the Candida albicans Als2p and Als4p adhesins suggests the potential for compensatory function within the Als family. Microbiology 151: 1619–1630. [PubMed][CrossRef] · DOI · Paper page
  17. Davey ME Caiazza NC O’Toole GA. 2003. Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1. J Bacteriol 185: 1027–1036. [PubMed][CrossRef] · DOI · Paper page
  18. Shopova I Bruns S Thywissen A Kniemeyer O Brakhage AA Hillmann F. 2013. Extrinsic extracellular DNA leads to biofilm formation and colocalizes with matrix polysaccharides in the human pathogenic fungus Aspergillus fumigatus . Front Microbiol 4: 141. [PubMed][CrossRef] · DOI · Paper page
  19. Krappmann S Ramage G. 2013. A sticky situation: extracellular DNA shapes Aspergillus fumigatus biofilms. Front Microbiol 4: 159. [PubMed][CrossRef] · DOI
  20. Wang R Khan BA Cheung GY Bach TH Jameson-Lee M Kong KF Queck SY Otto M. 2011. Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. J Clin Invest 121: 238–248. [PubMed][CrossRef] · DOI · Paper page
  21. Periasamy S Joo HS Duong AC Bach TH Tan VY Chatterjee SS Cheung GY Otto M. 2012. How Staphylococcus aureus biofilms develop their characteristic structure. Proc Natl Acad Sci USA 109: 1281–1286. [PubMed][CrossRef] · DOI · Paper page
  22. Harriott MM Noverr MC. 2009. Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob Agents Chemother 53: 3914–3922. [PubMed][CrossRef] · DOI · Paper page
  23. Demuyser L Jabra-Rizk MA Van Dijck P. 2014. Microbial cell surface proteins and secreted metabolites involved in multispecies biofilms. Pathog Dis 70: 219–230. [PubMed][CrossRef] · DOI
  24. Shirtliff ME Peters BM Jabra-Rizk MA. 2009. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol Lett 299: 1–8. [PubMed][CrossRef] · DOI · Paper page
  25. Peters BM Jabra-Rizk MA Scheper MA Leid JG Costerton JW Shirtliff ME. 2010. Microbial interactions and differential protein expression in Staphylococcus aureus-Candida albicans dual-species biofilms. FEMS Immunol Med Microbiol 59: 493–503. [PubMed][CrossRef] · DOI · Paper page
  26. Wolcott R Costerton JW Raoult D Cutler SJ. 2013. The polymicrobial nature of biofilm infection. Clin Microbiol Infect 19: 107–112. [PubMed][CrossRef] · DOI · Paper page
  27. Christensen GD Simpson WA Younger JJ Baddour LM Barrett FF Melton DM Beachey EH. 1985. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22: 996–1006. [PubMed] · DOI · Paper page
  28. Hassan A Usman J Kaleem F Omair M Khalid A Iqbal M. 2011. Evaluation of different detection methods of biofilm formation in the clinical isolates. Braz J Infect Dis 15: 305–311. [PubMed][CrossRef] · DOI
  29. Taff HT Nett JE Andes DR. 2012. Comparative analysis of Candida biofilm quantitation assays. Med Mycol 50: 214–218. [PubMed][CrossRef] · DOI · Paper page
  30. Sontakke S Cadenas MB Maggi RG Diniz PP Breitschwerdt EB. 2009. Use of broad range 16S rDNA PCR in clinical microbiology. J Microbiol Methods 76: 217–225. [PubMed][CrossRef] · DOI
  31. Pontes DS Lima-Bittencourt CI Chartone-Souza E Amaral Nascimento AM. 2007. Molecular approaches: advantages and artifacts in assessing bacterial diversity. J Ind Microbiol Biotechnol 34: 463–473. [PubMed][CrossRef] · DOI
  32. Rhoads DD Wolcott RD Sun Y Dowd SE. 2012. Comparison of culture and molecular identification of bacteria in chronic wounds. Int J Mol Sci 13: 2535–2550. [PubMed][CrossRef] · DOI · Paper page
  33. Banchereau J Briere F Caux C Davoust J Lebecque S Liu YJ Pulendran B Palucka K. 2000. Immunobiology of dendritic cells. Annu Rev Immunol 18: 767–811. [PubMed][CrossRef] · DOI · Paper page
  34. Gantner BN Simmons RM Canavera SJ Akira S Underhill DM. 2003. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 197: 1107–1117. [PubMed][CrossRef] · DOI · Paper page
  35. Norrby-Teglund A Johansson L. 2013. Beyond the traditional immune response: bacterial interaction with phagocytic cells. Int J Antimicrob Agents 42 (Suppl) : S13–S16. [PubMed][CrossRef] · DOI
  36. Overhage J Campisano A Bains M Torfs EC Rehm BH Hancock RE. 2008. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 76: 4176–4182. [PubMed][CrossRef] · DOI · Paper page
  37. Britigan BE Hayek MB Doebbeling BN Fick RB Jr. 1993. Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa -infected lungs of patients with cystic fibrosis. Infect Immun 61: 5049–5055. [PubMed] · DOI · Paper page
  38. Schmidtchen A Frick IM Andersson E Tapper H Bjorck L. 2002. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol 46: 157–168. [PubMed][CrossRef] · DOI · Paper page
  39. Jensen PO Givskov M Bjarnsholt T Moser C. 2010. The immune system vs. Pseudomonas aeruginosa biofilms. FEMS Immunol Med Microbiol 59: 292–305. [PubMed][CrossRef] · DOI · Paper page
  40. Meyle E Stroh P Gunther F Hoppy-Tichy T Wagner C Hansch GM. 2010. Destruction of bacterial biofilms by polymorphonuclear neutrophils: relative contribution of phagocytosis DNA release and degranulation. Int J Artif Organs 33: 608–620. [PubMed] · DOI
  41. Gunther F Wabnitz GH Stroh P Prior B Obst U Samstag Y Wagner C Hansch GM. 2009. Host defense against Staphylococcus aureus biofilms infection: phagocytosis of biofilms by polymorphonuclear neutrophils (PMN). Mol Immunol 46: 1805–1813. [PubMed][CrossRef] · DOI
  42. Meyle E Brenner-Weiss G Obst U Prior B Hansch GM. 2012. Immune defense against S. epidermidis biofilms: components of the extracellular polymeric substance activate distinct bactericidal mechanisms of phagocytic cells. Int J Artif Organs 35: 700–712. [PubMed][CrossRef] · DOI
  43. Chandra J McCormick TS Imamura Y Mukherjee PK Ghannoum MA. 2007. Interaction of Candida albicans with adherent human peripheral blood mononuclear cells increases C. albicans biofilm formation and results in differential expression of pro- and anti-inflammatory cytokines. Infect Immun 75: 2612–2620. [PubMed][CrossRef] · DOI · Paper page
  44. Katragkou A Kruhlak MJ Simitsopoulou M Chatzimoschou A Taparkou A Cotten CJ Paliogianni F Diza-Mataftsi E Tsantali C Walsh TJ Roilides E. 2010. Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents. J Infect Dis 201: 1941–1949. [PubMed][CrossRef] · DOI · Paper page
  45. Martinez LR Casadevall A. 2006. Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system. Infect Immun 74: 6118–6123. [PubMed][CrossRef] · DOI · Paper page
  46. Archer NK Mazaitis MJ Costerton JW Leid JG Powers ME Shirtliff ME. 2011. Staphylococcus aureus biofilms: properties regulation and roles in human disease. Virulence 2: 445–459. [PubMed][CrossRef] · DOI · Paper page
  47. Leid JG Shirtliff ME Costerton JW Stoodley P. 2002. Human leukocytes adhere to penetrate and respond to Staphylococcus aureus biofilms. Infect Immun 70: 6339–6345. [PubMed][CrossRef] · DOI · Paper page
  48. Guenther F Stroh P Wagner C Obst U Hansch GM. 2009. Phagocytosis of staphylococci biofilms by polymorphonuclear neutrophils: S. aureus and S. epidermidis differ with regard to their susceptibility towards the host defense. Int J Artif Organs 32: 565–573. [PubMed] · DOI · Paper page
  49. Thurlow LR Hanke ML Fritz T Angle A Aldrich A Williams SH Engebretsen IL Bayles KW Horswill AR Kielian T. 2011. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo . J Immunol 186: 6585–6596. [PubMed][CrossRef] · DOI · Paper page
  50. Stroh P Gunther F Meyle E Prior B Wagner C Hansch GM. 2011. Host defense against Staphylococcus aureus biofilms by polymorphonuclear neutrophils: oxygen radical production but not phagocytosis depends on opsonisation with immunoglobulin G. Immunobiology 216: 351–357. [PubMed][CrossRef] · DOI
  51. Cerca N Jefferson KK Oliveira R Pier GB Azeredo J. 2006. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect Immun 74: 4849–4855. [PubMed][CrossRef] · DOI · Paper page
  52. Hanke ML Kielian T. 2012. Deciphering mechanisms of staphylococcal biofilm evasion of host immunity. Front Cell Infect Microbiol 2: 62. [PubMed][CrossRef] · DOI
  53. Hanke ML Heim CE Angle A Sanderson SD Kielian T. 2013. Targeting macrophage activation for the prevention and treatment of Staphylococcus aureus biofilm infections. J Immunol 190: 2159–2168. [PubMed][CrossRef] · DOI · Paper page
  54. Alhede M Bjarnsholt T Givskov M Alhede M. 2014. Pseudomonas aeruginosa biofilms: mechanisms of immune evasion. Adv Appl Microbiol 86: 1–40. [PubMed][CrossRef] · DOI · Paper page
  55. Jensen ET Kharazmi A Lam K Costerton JW Hoiby N. 1990. Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms. Infect Immun 58: 2383–2385. [PubMed] · DOI · Paper page
  56. Jesaitis AJ Franklin MJ Berglund D Sasaki M Lord CI Bleazard JB Duffy JE Beyenal H Lewandowski Z. 2003. Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J Immunol 171: 4329–4339. [PubMed][CrossRef] · DOI · Paper page
  57. Bjarnsholt T Jensen PO Burmolle M Hentzer M Haagensen JA Hougen HP Calum H Madsen KG Moser C Molin S Hoiby N Givskov M. 2005. Pseudomonas aeruginosa tolerance to tobramycin hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology 151: 373–383. [PubMed][CrossRef] · DOI · Paper page
  58. Parks QM Young RL Poch KR Malcolm KC Vasil ML Nick JA. 2009. Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy. J Med Microbiol 58: 492–502. [PubMed][CrossRef] · DOI · Paper page
  59. Watt AP Courtney J Moore J Ennis M Elborn JS. 2005. Neutrophil cell death activation and bacterial infection in cystic fibrosis. Thorax 60: 659–664. [PubMed][CrossRef] · DOI
  60. Leid JG Willson CJ Shirtliff ME Hassett DJ Parsek MR Jeffers AK. 2005. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J Immunol 175: 7512–7518. [PubMed][CrossRef] · DOI · Paper page
  61. Jensen ET Kharazmi A Hoiby N Costerton JW. 1992. Some bacterial parameters influencing the neutrophil oxidative burst response to Pseudomonas aeruginosa biofilms. APMIS 100: 727–733. [PubMed][CrossRef] · DOI · Paper page
  62. Jensen PO Bjarnsholt T Phipps R Rasmussen TB Calum H Christoffersen L Moser C Williams P Pressler T Givskov M Hoiby N. 2007. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa . Microbiology 153: 1329–1338. [PubMed][CrossRef] · DOI · Paper page
  63. Alhede M Bjarnsholt T Jensen PO Phipps RK Moser C Christophersen L Christensen LD van Gennip M Parsek M Hoiby N Rasmussen TB Givskov M. 2009. Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. Microbiology 155: 3500–3508. [PubMed][CrossRef] · DOI · Paper page
  64. Van Gennip M Christensen LD Alhede M Phipps R Jensen PO Christophersen L Pamp SJ Moser C Mikkelsen PJ Koh AY Tolker-Nielsen T Pier GB Hoiby N Givskov M Bjarnsholt T. 2009. Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production disabling the protection against polymorphonuclear leukocytes. APMIS 117: 537–546. [PubMed][CrossRef] · DOI · Paper page
  65. Roilides E Walsh T. 2004. Recombinant cytokines in augmentation and immunomodulation of host defenses against Candida spp. Med Mycol 42: 1–13. [PubMed][CrossRef] · DOI
  66. Xie Z Thompson A Sobue T Kashleva H Xu H Vasilakos J Dongari-Bagtzoglou A. 2012. Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing. J Infect Dis 206: 1936–1945. [PubMed][CrossRef] · DOI · Paper page
  67. Katragkou A Simitsopoulou M Chatzimoschou A Georgiadou E Walsh TJ Roilides E. 2011. Effects of interferon-gamma and granulocyte colony-stimulating factor on antifungal activity of human polymorphonuclear neutrophils against Candida albicans grown as biofilms or planktonic cells. Cytokine 55: 330–334. [PubMed][CrossRef] · DOI
  68. Nett J Lincoln L Marchillo K Andes D. 2007. Beta -1 3 glucan as a test for central venous catheter biofilm infection. J Infect Dis 195: 1705–1712. [PubMed][CrossRef] · DOI · Paper page
  69. Dongari-Bagtzoglou A Kashleva H Dwivedi P Diaz P Vasilakos J. 2009. Characterization of mucosal Candida albicans biofilms. PLoS One 4: e7967. doi:10.1371/journal.pone.0007967. [PubMed][CrossRef] · DOI · Paper page
  70. Al-Fattani MA Douglas LJ. 2006. Biofilm matrix of Candida albicans and Candida tropicalis : chemical composition and role in drug resistance. J Med Microbiol 55: 999–1008. [PubMed][CrossRef] · DOI · Paper page
  71. Giard JC Riboulet E Verneuil N Sanguinetti M Auffray Y Hartke A. 2006. Characterization of Ers a PrfA-like regulator of Enterococcus faecalis . FEMS Immunol Med Microbiol 46: 410–418. [PubMed][CrossRef] · DOI
  72. Gentry-Weeks CR Karkhoff-Schweizer R Pikis A Estay M Keith JM. 1999. Survival of Enterococcus faecalis in mouse peritoneal macrophages. Infect Immun 67: 2160–2165. [PubMed] · DOI
  73. Daw K Baghdayan AS Awasthi S Shankar N. 2012. Biofilm and planktonic Enterococcus faecalis elicit different responses from host phagocytes in vitro . FEMS Immunol Med Microbiol 65: 270–282. [PubMed][CrossRef] · DOI
  74. Mathew S Yaw-Chyn L Kishen A. 2010. Immunogenic potential of Enterococcus faecalis biofilm under simulated growth conditions. J Endod 36: 832–836. [PubMed][CrossRef] · doi:10.1016/j.joen.2010.02.022
  75. Chotirmall SH McElvaney NG. 2014. Fungi in the cystic fibrosis lung: bystanders or pathogens? Int J Biochem Cell Biol 52: 161–173. [PubMed][CrossRef] · DOI
  76. Roilides E Simitsopoulou M. 2010. Local innate host response and filamentous fungi in patients with cystic fibrosis. Med Mycol 48 (Suppl 1) : S22–S31. [PubMed][CrossRef] · DOI
  77. Tasina E Simitsopoulou M Roilides E. 2012. The innate immune response to filamentous fungi in patients with cystic fibrosis. CML Cystic Fibrosis 2: 29–39. · doi:10.5275/ijcr.2012.09.03
  78. Kreindler JL Steele C Nguyen N Chan YR Pilewski JM Alcorn JF Vyas YM Aujla SJ Finelli P Blanchard M Zeigler SF Logar A Hartigan E Kurs-Lasky M Rockette H Ray A Kolls JK. 2010. Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J Clin Invest 120: 3242–3254. [PubMed][CrossRef] · DOI · Paper page

Cited by

See all 157

Metadata

Authors
Roilides, E., Simitsopoulou, M., Katragkou, A., & Walsh, T. J.
Venue
Microbiology Spectrum
Published
2015-06-18
Volume
3
Issue
3
ISSN
2165-0497 (ISSN-L)
OpenAlex
W2214330682
Cited by
157
References
14
FWCI
3.47
Type
journal article
Language
en
Open access
closed
Licence
journals.asm.org/non-commercial-tdm-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: How Biofilms Evade Host Defenses. https://app.cochat.ai/papers/10.1128/microbiolspec.mb-0012-2014
The paper
Roilides, E., Simitsopoulou, M., Katragkou, A., & Walsh, T. J. (2015). How Biofilms Evade Host Defenses. Microbiology Spectrum. https://doi.org/10.1128/microbiolspec.mb-0012-2014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.